Mercado de tratamiento de la enfermedad inflamatoria intestinal: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00003491
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

RESUMEN DEL MERCADO

Enfermedad inflamatoria intestinal (EII) es un término que se Se utiliza para describir los trastornos que implican inflamación crónica del tracto digestivo. Los dos tipos de EII incluyen, a saber, la colitis ulcerosa y la enfermedad de Crohn, que generalmente implican diarrea intensa, dolor abdominal, fatiga y pérdida de peso. El tratamiento de la EII consiste en reducir la inflamación que desencadena los signos y síntomas. El tratamiento implica terapia con medicamentos o cirugía. La terapia con medicamentos incluye medicamentos antiinflamatorios que incluyen además corticosteroides y aminosalicilatos como mesalamina (Asacol HD, Delzicol, otros), balsalazida (Colazal) y olsalazina (Dipentum), según el área afectada del colon.< /p>

ÁMBITO DEL MERCADO

La

“inflamatoria global El análisis del mercado de tratamiento de enfermedades intestinales hasta 2028 es un estudio especializado y en profundidad de la industria de dispositivos médicos con un enfoque especial en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de tratamiento de la enfermedad inflamatoria intestinal con una segmentación detallada del mercado por tipo de clase de fármaco, indicación de enfermedad, canal de distribución y geografía. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de tratamiento de la enfermedad inflamatoria intestinal y ofrece tendencias y oportunidades clave en el mercado.

SEGMENTACIÓN DEL MERCADO

  • Según el tipo de clase de fármaco, el mercado se segmenta en aminosaliciclatos, inmunomoduladores, inhibidores del TNF y corticosteroides.
  • Según la indicación de la enfermedad, el mercado se segmenta en enfermedad de Crohn y colitis ulcerosa
  • Según el canal de distribución, el mercado mundial de tratamiento de la enfermedad inflamatoria intestinal se clasifica como farmacia hospitalaria, farmacia en línea y farmacia minorista.
< p estilo="altura de línea: 150%; margen: 0pulg 0pulg 8pt; tamaño de fuente: 11 puntos; familia de fuentes: Calibri, sans-serif;">

DINÁMICA DEL MERCADO

Controladores:

  • Presencia de potentes productos en desarrollo para el tratamiento de la enfermedad inflamatoria intestinal (EII)
  • Prevalencia creciente de la enfermedad de Crohn y la colitis ulcerosa

Restricciones:

  • Alto costo del tratamiento

MARCO REGIONAL

El informe proporciona una descripción detallada de la industria que incluye información cualitativa y cuantitativa. Proporciona una descripción general y un pronóstico del mercado global basado en varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico para el año 2019 a 2028 con respecto a cinco regiones principales, a saber: América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur. El mercado de tratamiento de la enfermedad inflamatoria intestinal por Posteriormente, cada región se subsegmenta en sus respectivos países y segmentos. El informe cubre el análisis y pronóstico de 18 países a nivel mundial junto con la tendencia actual y las oportunidades que prevalecen en la región.

El informe analiza los factores que afectan al mercado tanto desde el lado de la demanda como de la oferta y evalúa más a fondo la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber: América del Norte, Europa, APAC, MEA y América del Sur después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado del tratamiento de la enfermedad inflamatoria intestinal en estas regiones.

IMPACTO DEL COVID-19 EN EL MERCADO DEL TRATAMIENTO DE LAS ENFERMEDADES INFLAMATORIAS DEL INTESTINO

El COVID-19 comenzó en Wuhan (China) durante diciembre de 2019 y desde entonces se ha extendido a un ritmo rápido por todo el país. Estados Unidos, India, Brasil, Rusia, Francia, Reino Unido, Turquía, Italia y España son algunos de los países más afectados en términos de casos confirmados y muertes reportadas. La pandemia de COVID-19 ha aumentado la demanda de enfermedades inflamatorias intestinales. tratamiento en todo el mundo.

Debido a la situación de COVID 19, muchas de las empresas se centraron en el desarrollo de vacunas, productos biológicos y medicamentos eficaces para prevenir/curar la enfermedad. Sin embargo, debido a Debido a la desaceleración del desarrollo y la fabricación de otros productos farmacéuticos o biológicos, junto con la interrupción de la cadena de suministro, el mercado ha sido testigo de dificultades en 2020. Además, debido a las diversas limitaciones del bloqueo, la atención a los niños con EII se ha mantenido en estándares mínimos. priorizando las urgencias y las infusiones de biológicos e implementando servicios de telemedicina.

JUGADORES DEL MERCADO

El informe cubre desarrollos clave en el mercado del tratamiento de la enfermedad inflamatoria intestinal como estrategias de crecimiento orgánico e inorgánico. Varias empresas se están centrando en estrategias de crecimiento orgánico, como lanzamientos de productos, aprobaciones de productos y otros. tales como patentes y eventos. Las actividades de estrategias de crecimiento inorgánico presenciadas en el mercado fueron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se anticipan los contribuyentes del mercado del mercado de tratamiento de enfermedades inflamatorias intestinales. a lucrativas oportunidades de crecimiento en el futuro con la creciente demanda de tratamiento de enfermedades inflamatorias intestinales en el mercado global.

El informe también incluye los perfiles de empresas clave junto con su análisis FODA y estrategias de mercado en el mercado de tratamiento de la enfermedad inflamatoria intestinal. Además, el informe se centra en los principales actores de la industria con información como perfiles de la empresa, componentes y servicios ofrecidos, información financiera de los últimos 3 años, el desarrollo clave en los últimos cinco años.

  • Pfizer Inc.
  • Novartis AG
  • JOHNSON y JOHNSON (Janssen Global Services, LLC)
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • ALLERGAN
  • CELGENE CORPORATION
  • Bausch Health
  • UCB, Inc.
  • Cosmo Pharmaceuticals NV

El equipo dedicado de investigación y análisis de Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports